搜尋結果
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 1 日前Eli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters· 4 小時前, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales forecast ...
These Homes By Big-Name Architects Just Hit The Market—With Curved Walls And Built-In Furniture ...
Forbes· 5 日前Two homes designed by celebrated architects Eric Owen Moss and Marcel Breuer recently went up ...
Packers Earn High Marks From Draft ‘Experts’
Forbes· 2 日前Ron Wolf, the Hall of Fame general manager who led a football renaissance in Green Bay a ...
150th Kentucky Derby Brings Celebrations And Activities For Fans
Forbes· 15 小時前The Kentucky Derby has always gone far beyond “the most exciting two minutes in sports,” with ...
Exclusive: Employers Are Souring On Ivy League Grads, While These 20 “New Ivies” Ascend
Forbes· 2 日前For the entirety of America’s existence, the Ivy League has provided an essential service. In ...
Warren Buffett loves dividend-paying stocks, but Berkshire doesn't pay one — Here's why
CNBC· 2 日前Warren Buffett is a fan of buying dividend-paying stocks, but his conglomerate Berkshire ...
How Cirque Du Soleil's Icy Acrobatic Show Swings Into The Desert
Forbes· 15 小時前The glitzy Middle Eastern Emirate is home to the world's biggest aquarium, the world's ...
Suffragists Take The Spotlight In The Broadway Musical ‘Suffs’
Forbes· 15 小時前Nominated for six Tony Awards, including Best Musical, Suffs is the first Broadway musical to ...
Bears Fill Out Class With Trio Of Players Found In The Shadows
Forbes· 2 日前Make no mistake about it: The Bears’ draft will be judged on the success or failure of the ...